1Role of the histone methyltransferases Ezh2 and Suv4-20h1/Suv4-20h2 in neurogenesisChristopher T.Rhodes, Chin-Hsing Annie Lin469-4732Lights at night:does photobiomodulation improve sleep?Audrey Valverde, Catherine Hamilton, Cécile Moro, Malvina Billeres, Pierre Magistretti, John Mitrofanis474-4773Combined cell-based therapy strategies for the treatment of Parkinson's disease:focus on mesenchymal stromal cellsJannette Rodríguez-Pallares, María García-Garrote, Juan A.Parga, José Luis Labandeira-García478-4844The lymphatic drainage systems in the brain:a novel target for ischemic stroke?Ying-Jie Wang, Yan-Rong Sun, Yan-Hong Pei, Hao-Wen Ma, Ya-Kun Mu, Li-Hua Qin, Jun-Hao Yan485-4915Neuroprotective role of Noggin in spinal cord injuryNadia Al-Sammarrraie, Mohammed Mahmood, Swapan K.Ray492-4966Ataxia-telangiectasia mutated plays an important role in cerebellar integrity and functionalityYulia Mitiagin, Ari Barzilai497-5027Melatonin:a multitasking indoleamine to modulate hippocampal neurogenesisAlejandro Romero, José ángel Morales-García, Eva Ramos503-5058Ferroptosis:a critical player and potential therapeutic target in traumatic brain injury and spinal cord injuryQing-Sheng Li, Yan-Jie Jia506-5129Inflammation and retinal degenerative diseasesGeetika Kaur, Nikhlesh K.Singh513-51810SARS-CoV-2 getting into the brain;neurological phenotype of COVID-19,and management by nano-biotechnologyMa?gorzata Kujawska, Ebrahim Mostafavi, Ajeet Kaushik519-52011Choroid plexus imaging to track neuroinflammation-a translational model for mouse and human studiesMuthuraman Muthuraman, Mohammadsaleh Oshaghi, Vinzenz Fleischer, Dumitru Ciolac, Ahmed Othman, Sven G.Meuth, Gabriel Gonzalez-Escamilla, Sergiu Groppa521-52212Striatum-specific mechanisms regulate neuronal cell cycle re-entry:the choice between life and deathPaula Dietrich, Ioannis Dragatsis523-52413Biofabrication of nanovesicles for brain diseasesPasquale Picone, Domenico Nuzzo525-52614Developmental exposure to thyroid disruptors:misprogramming of the brain's stem cells in later life?Pieter Vancamp, Sylvie Remaud527-52815Nucleoredoxin-like 2 metabolic signaling impairs its potential contribution to neurodegenerative diseasesMariangela Corsi, Céline Jaillard, Thierry Léveillard529-53016Synaptic alterations as a common phase in neurological and neurodevelopmental diseases:JNK is a key mediator in synaptic changesClara Alice Musi, Carlo Bonadonna, Tiziana Borsello531-53217Axonal tuning by GABAA receptor unveils novel tricks from an old dogVeronica Bonalume, Valerio Magnaghi533-53418CD34+progenitor cells as diagnostic and therapeutic targets in Alzheimer's diseaseDaniel Romaus-Sanjurjo, Antía Custodia, Alberto Ouro, Tomás Sobrino535-53619Treating peripheral nerve injury-induced spinal cord degeneration and neuropathic pain with peripherally administrated stem cellsZihui Wang, Xiaofeng Jia537-53820Technological advances expand our knowledge of lysosomal dysfunction in neurodegenerationChase Chen, Yu Chen, Ellen Sidransky539-540 